ArticleClinical rheumatology2019

Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.

Yasunori Iida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.